Eisai
4523.T
#2184
Rank
ยฃ6.35 B
Marketcap
ยฃ22.51
Share price
0.11%
Change (1 day)
-1.87%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

P/E ratio for Eisai (4523.T)

P/E ratio as of December 2025 (TTM): 34.6

According to Eisai's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.6095. At the end of 2025 the company had a P/E ratio of 25.1.

P/E ratio history for Eisai from 2009 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202525.1-36.98%
202439.89.65%
202336.312.93%
202232.1177.77%
202111.6182.87%
20204.09-33.15%
20196.12-23.03%
20187.95-9.66%
20178.8021.22%
20167.26-36.93%
201511.5102.7%
20145.6827.26%
20134.4655.25%
20122.8733.67%
20112.15-44.76%
20103.8940.74%
20092.76-132.61%
2008-8.48-355.7%
20073.320.67%
20063.2924.97%
20052.6417.72%
20042.244.35%
20032.14-36.85%
20023.40-36.17%
20015.32

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.